Patent: 9,541,560
✉ Email this page to a colleague
Summary for Patent: 9,541,560
Title: | Serological markers of inflammatory bowel disease phenotype and disease progression |
Abstract: | Disclosed are novel biomarkers and methods related to diagnostic tests for the detection and characterization of inflammatory bowel diseases, such as Crohn\'s disease and ulcerative colitis. In particular, the instant invention relates to novel biomarkers and methods of using such biomarkers to predict disease behavior and severity, to differentiate among disease types, and to optimize selection of treatment options in individuals suspected of having an inflammatory bowel disease. |
Inventor(s): | Denson; Lee (Wyoming, OH), Trapnel; Bruce Colston (Hamilton, OH), Uchida; Kanji (Tokyo, JP) |
Assignee: | Children\'s Hospital Medical Center (Cincinnati, OH) |
Application Number: | 14/686,628 |
Patent Claims: | see list of patent claims |
Details for Patent 9,541,560
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Partner Therapeutics, Inc. | LEUKINE | sargramostim | For Injection | 103362 | 03/05/1991 | ⤷ Try a Trial | 2027-03-30 |
Partner Therapeutics, Inc. | LEUKINE | sargramostim | Injection | 103362 | 03/05/1991 | ⤷ Try a Trial | 2027-03-30 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |